

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
“The governor’s decision leaves the commonwealth exactly where we have been since 2021: with an unchecked illicit market hurting our communities, harming our youth, and putting adults at risk," said one critic.
Criminal justice reform and cannabis legalization advocates led condemnation of Democratic Virginia Gov. Abigail Spanberger's Tuesday veto of legislation that would have established a retail market for the sale of recreational-use marijuana, which has been legal in the state for five years.
In 2021, Virginia became the then-16th state to pass an adult-use marijuana legalization law, with sales set to begin in 2024. However, former Republican Gov. Glenn Youngkin repeatedly vetoed the legislation, which would establish the framework for regulating and taxing the plant's recreational use.
Today, while adults can legally consume cannabis recreationally, cannabis sales in Virginia are still restricted to medical use, and patients must travel to one of the five licensed providers in the commonwealth.
In March, Virginia lawmakers passed a package of bills to legalize recreational cannabis sales to people age 21 and older via a regulated market, place oversight of such sales under the Virginia Cannabis Control Authority, increase the public possession limit from one ounce to 2.5 ounces, allow delivery sales, establish new state and local cannabis taxes, and set January 1, 2027 as the launch date for sales.
Spanberger—who had campaigned on a promise to sign legislation establishing recreational cannabis sales—proposed amendments to the bill that were rejected by the General Assembly.
“I support the intent of many of the bills I am vetoing," she explained in a statement. "However, it is my responsibility as governor to make sure all new laws can be successfully implemented and protect against unintended consequences that harm Virginians."
"I look forward to continuing to work with bill patrons, state and local leaders, and advocates on legislation addressing these issues in the future," the governor said.
Marijuana Moment reported that Spangberger sought to delay the start of sales by six months, increase taxes, and institute new criminal penalties for cannabis consumers.
“Once again, Virginia’s efforts to establish a safe, regulated, and equitable adult-use cannabis marketplace has been halted despite years of work, public input, and broad recognition that the status quo is failing Virginians," state Sen. Lashrecse Aird (D-63), who sponsored one of the bills, said in a statement Tuesday.
“The governor’s decision leaves the commonwealth exactly where we have been since 2021: with an unchecked illicit market hurting our communities, harming our youth, and putting adults at risk," she added.
Del. Paul Krizek (D-16), who sponsored the House of Delegates version of the sales bill, said, “Five years ago, Virginia legalized cannabis in recognition that the War on Drugs has caused disproportionate harm to Black families and communities."
“The question now is whether Virginia will continue allowing an unregulated illegal market to thrive, or finally establish a safe, transparent system that protects consumers, keeps products away from children, and keeps our commitment to ending racially discriminatory marijuana policing in Virginia," he added.
JM Pedini, development director for the advocacy group National Organization for the Reform of Marijuana Laws and executive director for Virginia NORML, told Marijuana Moment that Spanberger's veto is “a profound disappointment to the many Virginia voters who believed her when she said on the campaign trail that she supported establishing a regulated adult-use cannabis market.”
“It is also a slap in the face to the years of serious work undertaken by lawmakers, policy experts, advocates, public health stakeholders, and regulators who spent more than half a decade researching, debating, and carefully crafting this legislation,” Pedini added. “Rather than build upon that work, the governor dismissed it in favor of out-of-touch proposals to recriminalize cannabis consumers that lawmakers rightly rejected.”
It was stupid when Youngkin stood in the way of a regulated market for LEGAL recreational adult-use marijuana--not just for the important safety aspects of taking it off the black market, but also for the $ Virginia misses out on every day without. It is just as stupid now.
— VAPLAN (@vaplan.bsky.social) May 19, 2026 at 2:26 PM
Chelsea Higgs Wise, executive director of the Richmond-based nonprofit Marijuana Justice, said in a statement that "for five years, Virginia has been stuck in a limbo where adults can legally possess, share, and grow cannabis, but there is still no regulated way to purchase it."
"By rejecting the retail bill," Wise added, "the governor has chosen to extend that chaos rather than move us toward a transparent, accountable retail system that centers public health, public safety, and justice."
Twenty-four states have legalized recreational marijuana, while 16 states allow medical use of the plant. Last month, the US Department of Justice began reclassifying cannabis from Schedule I—a category that includes dangerous drugs like heroin, LSD, and MDMA to Schedule III, which includes codeine, ketamine, anabolic steroids, and testosterone.
Sen. Cory Booker urged fellow lawmakers to "follow the lead of states around the country and legalize cannabis for adult use and create a comprehensive taxation and regulatory scheme."
U.S. marijuana legalization advocates greeted Tuesday's news that the Drug Enforcement Administration is proposing rescheduling cannabis to a less restrictive class by calling on President Joe Biden to fully deschedule the plant, which is approved for recreational or medicinal use in the vast majority of states.
The Associated Press reported the DEA is proposing rescheduling marijuana from Schedule I—which includes heroin, MDMA, and LSD—to Schedule III, a far less restrictive class that includes ketamine, anabolic steroids, testosterone, and over-the-counter products containing less than 90 milligrams of codeine per dose. According to the DEA, Schedule I drugs have "no currently accepted medical use and a high potential for abuse."
While it would not legalize cannabis for recreational use, the DEA proposal—which is subject to review by the White House Office of Management and Budget—would affirm medicinal marijuana and recognize that the plant has a lower potential for abuse than other widely used recreational drugs.
The Drug Policy Alliance (DPA)—which works to end the failed 53-year War on Drugs—warned that "under this proposed shift, marijuana criminalization would continue at the federal level and most penalties, including those for simple possession, would continue as long as marijuana remains anywhere on the Controlled Substances Act (CSA)."
While running for president in 2020, Biden repeatedly vowed to decriminalize marijuana and expunge the criminal records of people convicted of cannabis possession. In 2022 the president issued a "full, complete, and unconditional pardon to all current United States citizens and lawful permanent residents" convicted of simple federal marijuana possession—a move that affected thousands of people but excluded those who are in the United States without authorization.
The following year, Health and Human Services (HHS) Secretary Xavier Becerraconfirmed that his department would recommend rescheduling cannabis to Schedule III.
Sen. Cory Booker (D-N.J.) on Tuesday urged Congress to "follow the lead of states around the country and legalize cannabis for adult use and create a comprehensive taxation and regulatory scheme."
"Thousands of people remain in prisons around the country for marijuana-related crimes. Thousands of people continue to bear the devastating collateral consequences that come with a criminal record," the senator continued. "Legal marijuana businesses, especially those in communities hardest hit by the War on Drugs, still have to navigate a convoluted patchwork of state laws and regulatory schemes."
"I hope that my colleagues on both sides of the aisle, especially those who represent constituents benefiting from medical or adult-use programs, join me to pass federal legislation to fix these problems," Booker added.
Senate Majority Leader Chuck Schumer (D-N.Y.) said that "it is great news that DEA is finally recognizing that restrictive and draconian cannabis laws need to change to catch up to what science and the majority of Americans have said loud and clear."
"While this rescheduling announcement is a historic step forward, I remain strongly committed to continuing to work on legislation like the SAFER Banking Act as well as the Cannabis Administration and Opportunity Act, which federally deschedules cannabis by removing it from the Controlled Substances Act," he added.
Booker and Schumer were among the 21 senators who last week sent a letter to U.S. Attorney General Merrick Garland and DEA Administrator Anne Milgram noting that it's been 18 months since Biden ordered HHS October to review cannabis scheduling and eight months since the agency's rescheduling recommendation.
"While we understand that the DEA may be navigating internal disagreement on this matter, it is critical that the agency swiftly correct marijuana's misguided placement in Schedule I," the letter states.
Legalization advocates, meanwhile, pushed the Biden administration to go much further, as 24 states plus the District of Columbia have approved adult-use recreational marijuana and 38 states have legalized medicinal cannabis.
"Supporting federal marijuana decriminalization means supporting the removal of marijuana from the Controlled Substances Act, not changing its scheduling," DPA director of drug markets and legal regulation Cat Packer said in a statement. "We all deserve a federal framework for marijuana that upholds the health, well-being, and safety of our communities—particularly Black communities who have borne the brunt of our country's racist enforcement of marijuana laws."
"Rescheduling marijuana is not a policy solution for federal marijuana criminalization or its harms, and it won't address the disproportionate impact that it has had on Black and Brown communities," Packer added.
Dasheeda Dawson, chair of the Cannabis Regulators of Color Coalition and founder of Cannabis NYC, said: "The time for descheduling cannabis is not just a matter of policy; it's an imperative for justice and equity. Rescheduling would undermine the hard-fought progress made by cannabis equity and policy reform leaders like the Cannabis Regulators of Color Coalition, jeopardizing the livelihoods and futures of those entrepreneurs and communities disproportionately affected by past criminalization."
"We cannot afford to backtrack on our commitment to repair the harm inflicted by outdated policies," Dawson added. "Descheduling is not just about legality; it's about rectifying historic injustices and ensuring a fair and inclusive future for all."
"As more states have adopted legalization, public support for this policy has risen dramatically," said one campaigner. "Voters prefer legalization and regulation over the failed policy of marijuana prohibition."
A record 7 in 10 voting-age Americans think marijuana should be legal, according to Gallup polling published Wednesday, a day after voters in Ohio made it the 24th state to legalize adult recreational use of the plant.
After holding steady at 68% for three straight years, Gallup found that support for legalization rose to 70%, with 29% of respondents saying cannabis should not be legal and 1% undecided. That's a 12% increase in support from 2013 levels and a 36% rise from 2003. In 1969, when Gallup first asked Americans if marijuana should be legal, only 12% said "yes."
"There's no 'buyer's remorse' among the public when it comes to legalizing cannabis," Paul Armentano, deputy director at the National Organization for the Reform of Marijuana Laws (NORML), said in a statement. "As more states have adopted legalization, public support for this policy has risen dramatically. That's because these policies are largely working as intended and because voters prefer legalization and regulation over the failed policy of marijuana prohibition."
According to Gallup:
For the second straight year, majority support for legalization is found among all major subgroups, including by age, political party, and ideology. Self-identified conservatives were the last major subgroup to express majority support, reaching 51% in 2022. Republicans first gave marijuana majority-level backing in 2017.
As of today, support for legal marijuana use is highest among self-identified liberals (91%) and Democrats (87%) and lowest among conservatives (52%) and Republicans (55%). Support is inversely correlated with age, reaching 79% among 18- to 34-year-olds. However, even among the oldest age group, nearly two-thirds (64%) are in favor.
This widespread support for legal marijuana was evident on Tuesday as nearly 57% of voters in Ohio—a state that voted for former President Donald Trump in the last two elections and has a Republican governor—approved the legalization and regulation of marijuana for people age 21 and older, who are also allowed to grow up to six cannabis plants per person and 12 plants per residence. The measure imposes a 10% tax on cannabis sales.
"Marijuana is no longer a controversial issue," Tom Haren, spokesperson for the Coalition to Regulate Marijuana Like Alcohol, told Marijuana Moment. "Ohioans demonstrated this by passing State Issue 2 in a landslide."
Marijuana Policy Project interim executive director Matthew Schweich told MJBizDaily that the Ohio vote "shows that a cannabis legalization campaign can win anytime and anywhere."
"To achieve victory in a nonpresidential year in a red state shows just how strong public support for legalization has become," he added.
The rise in support for legal marijuana parallels "the rise in Americans' self-reported use of the drug," Gallup said, citing a July survey. "The percentage saying they personally smoke marijuana has risen 10 points to 17% since 2013, and the percentage who have ever tried it has increased 12 points to 50%."
Despite state-level gains—only 10 states have not legalized marijuana for recreational or medical use—cannabis remains strictly prohibited at the federal level, where the U.S. Drug Enforcement Administration (DEA) lists the plant as a Schedule I controlled substance.
Schedule I drugs, the DEA explains, have "no currently accepted medical use and a high potential for abuse," and in addition to cannabis include heroin, LSD, MDMA, and peyote. Far more dangerous substances than marijuana—including cocaine, methamphetamine, and fentanyl—are classified as Schedule II.
After granting a mass pardon last year to U.S. citizens and permanent residents convicted of simple federal marijuana possession, President Joe Biden ordered Attorney General Merrick Garland and Health and Human Services Secretary Xavier Becerra to initiate a review which resulted in an August recommendation by HHS to reclassify cannabis as Schedule III. Such a move would place the plant in the same category as codeine, ketamine, testosterone, and anabolic steroids.
"Just as it is intellectually dishonest to categorize cannabis in the same placement as heroin, it is equally disingenuous to treat cannabis in the same manner as anabolic steroids," Armentano said at the time. "The majority of Americans believe that cannabis ought to be legal and that its hazards to health are less significant than those associated with federally descheduled substances like alcohol and tobacco."
"Like those latter substances, we have long argued the cannabis plant should be removed from the Controlled Substances Act altogether," he added, "thereby proving state governments—rather than the federal government—the ability to regulate marijuana in the manner they see fit without violating federal law."
In the Democrat-controlled U.S. Senate, the bipartisan Secure and Fair Enforcement Regulation (SAFER) Banking Act—which would legally protect banks and credit unions that serve cannabis businesses—was approved by the Banking Committee in September.
Last week, a bipartisan group of U.S. House lawmakers reintroduced H.B. 6028, the States Reform Act, legislation led by Rep. Nancy Mace (R-S.C.) that would remove cannabis from the Controlled Substances Act, facilitate the expungement of certain marijuana-related offenses, and provide regulatory oversight for state-legal marijuana markets.
However, Republicans control the lower chamber, and new House Speaker Mike Johnson (R-La.) is a Christian fundamentalist who opposes marijuana on religious grounds. In recent years, Johnson has voted against legislation that would end federal prohibition, allow banks to work with state-legal cannabis businesses, and fund medical marijuana research.